Back
Gain Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
GANX
Gain Therapeutics, Inc.
Last Price:
$3.21
Seasonality Move:
19.87%
7 Day Trial
ALL ACCESS PASS
$
7
Gain Therapeutics, Inc. Stock Forecast
-
Is Gain Therapeutics, Inc. Stock Undervalued?The current Gain Therapeutics, Inc. [GANX] share price is $3.19. The Score for GANX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
GANX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Gain Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Gain Therapeutics, Inc. Stock Rating
Data Unavailable
Gain Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
gaintherapeutics.com
52-Week Data
52-Week High:
4.34
52-Week Low:
1.41
Prediction Charts
Market Cap:
115.6M
Price in USD:
3.19
Volume:
2.9M
Beta:
0.06
Technical Analysis
SMA50:
2.72
SMA100:
2.24
SMA200:
2.05
52-Wk Change:
104.49%
Stock Predictions
-
Is Gain Therapeutics, Inc. stock public?Yes, Gain Therapeutics, Inc. is a publicly traded company.
-
What is the Gain Therapeutics, Inc. stock quote today?The Gain Therapeutics, Inc. stock price is 3.19 USD today.
-
How to buy Gain Therapeutics, Inc. stock online?You can buy Gain Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 3.05 | 3.32 | 3.37 | 2.92 |
| Dec-4 | 3.31 | 3.50 | 3.50 | 3.17 |
| Dec-5 | 3.52 | 3.85 | 3.98 | 3.47 |
| Dec-8 | 3.84 | 3.99 | 4.18 | 3.60 |
| Dec-9 | 3.99 | 4.05 | 4.20 | 3.96 |
| Dec-10 | 4.01 | 4.18 | 4.22 | 3.95 |
| Dec-11 | 4.17 | 4.11 | 4.34 | 3.94 |
| Dec-12 | 4.20 | 4.14 | 4.30 | 4.03 |
| Dec-15 | 4.21 | 3.95 | 4.28 | 3.92 |
| Dec-16 | 3.95 | 3.86 | 4.18 | 3.81 |
| Dec-17 | 3.85 | 4.05 | 4.08 | 3.78 |
| Dec-18 | 3.56 | 2.25 | 3.62 | 2.14 |
| Dec-19 | 2.38 | 2.88 | 3.22 | 2.35 |
| Dec-22 | 2.94 | 3.19 | 3.30 | 2.75 |
Gain Therapeutics, Inc. Earnings
Data Unavailable
Gain Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.07 per share.
* Gain Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.